Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

688091 Shanghai Yizhong Pharmaceutical

Watchlist
72.350
-0.460-0.63%
Pre-Market Auction Session  12/07 09:30 CCT
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
72.810
Volume
0.00lot
Market Cap
10.41B
P/E(TTM)
86.54
52wk High
146.234
Shares
143.89M
P/E(Static)
Loss
52wk Low
31.654
Float Cap
7.54B
Bid/Ask %
71.43%
Historical High
146.234
Shs Float
104.19M
Volume Ratio
0.00
Historical Low
28.250
Dividend TTM
--
Div Yield TTM
--
P/B
11.06
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
100
Float Cap
7.54B
Bid/Ask %
71.43%
Historical High
146.234
Shs Float
104.19M
Volume Ratio
0.00
Historical Low
28.250
Dividend TTM
--
Limit Up
87.370
P/B
11.06
Dividend LFY
--
Limit Down
58.250
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
100
Ask
0lot
Bid
0lot
Price Forecast

No Data

News

Comment

Sign in to post a comment

    No comment yet

    Company Overview More
    The company is committed to the development of new dosage forms of antineoplastic drugs and related products. The company is committed to the R & D and industrialization of improved new drugs for antineoplastic drugs, with high-tech talents with the background of polymer materials, pharmaceutical preparations and biology, and mastering the core and key technologies for the synthesis of nano-drug carriers and medicinal polymer excipients. The company's main research and development product is paclitaxel micelles. Paclitaxel micelle is an innovative lyophilized powder injection without polyoxyethylene castor oil and methoxy polyethylene glycol 2000-poly (lactide) copolymer as carrier.
    CEO: Jingsong Zhou
    Market: --
    Listing Date: 09/09/2021
    Hot List
    TradeSearchNews
    SymbolLatest price%Chg

    Loading...

    Watchlist